Search Within

Biostatistics Service

  1. "Journal of Thoracic Oncology"
Formats
  1. Meeting Abstract (49)
  2. Journal Article (38)
  3. Correspondence (3)
Groups
  1. Epidemiology and Biostatistics (90)
  2. Surgery (63)
  3. Department of Pathology and Laboratory Medicine (48)
  4. Department of Medicine (45)
  5. Solid Tumor Oncology Division (45)
  6. Thoracic Oncology (45)

More Groups

People
  1. Prasad Adusumilli (39)
  2. Kay See Tan (38)
  3. William Travis (30)
  4. Mark Kris (26)
  5. Takashi Eguchi (22)
  6. Valerie Rusch (21)

More People

Years
  1. 2024 (2)
  2. 2023 (9)
  3. 2022 (2)
  4. 2021 (5)
  5. 2020 (6)
  6. 2019 (7)

More Years

Publications
  1. Journal of Thoracic Oncology (90)
Publishers
  1. Elsevier Inc. (90)

Results (90)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A real-world assessment of stage I lung cancer through electronic nose technology
    Journal Article

    Rocco, G.; Pennazza, G.; Tan, K. S.; Vanstraelen, S.; Santonico, M.; Corba, R. J.; Park, B. J.; Sihag, S.; Bott, M. J.; Crucitti, P.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Postoperative radiation therapy for thymic carcinoma: An analysis of the international thymic malignancy interest Group/European Society of Thoracic Surgeons database
    Journal Article

    Rimner, A.; Ahmad, U.; Lobaugh, S. M.; Zhang, Z.; Shepherd, A. F.; Huang, J.; Antonicelli, A.; Girard, N.; Moser, B.; Filosso, P.; more...
    Journal of Thoracic Oncology (2024)

    Fulltext@MSK | Save
  • Phase I dose escalation trial combining olaparib and thoracic radiation therapy in extensive-stage small cell lung cancer
    Meeting Abstract

    Rimner, A.; Lok, B.; Gelblum, D. Y.; Kotecha, R. R.; Albrecht, F.; Shin, J. Y.; Laplant, Q.; Namakydoust, A.; Shepherd, A.; Gomez, D.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • High-risk clinicopathologic and genomic features of recurrence in stage I lung adenocarcinoma
    Meeting Abstract

    Fick, C. N.; Dunne, E. G.; Mastrogiacomo, B.; Tan, K. S.; Toumbacaris, N.; Adusumilli, P. S.; Rocco, G.; Molena, D.; Huang, J.; Park, B. J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • The paradoxical behavior of Kappa when quantifying agreement in histological subtype classification among thoracic pathologists
    Meeting Abstract

    Tan, K. S.; Adusumilli, P.; Travis, W. D.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • The International Association for the Study of Lung Cancer grading system for recurrence and lung cancer-specific survival
    Meeting Abstract

    Tan, K. S.; Reiner, A.; Emoto, K.; Aly, R. G.; Rekhtman, N.; Adusumilli, P.; Travis, W.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Micropapillary and solid histologic patterns in N1 and N2 lymph node metastases are independent factors of poor prognosis in patients with stages II to III lung adenocarcinoma
    Journal Article

    Li, Y.; Byun, A. J.; Choe, J. K.; Lu, S.; Restle, D.; Eguchi, T.; Tan, K. S.; Saini, J.; Huang, J.; Rocco, G.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Central nervous system disease in patients with RET fusion-positive NSCLC treated with selpercatinib
    Journal Article

    Murciano-Goroff, Y. R.; Falcon, C. J.; Lin, S. T.; Chacko, C.; Grimaldi, G.; Liu, D.; Wilhelm, C.; Iasonos, A.; Drilon, A.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • Targeting NFE2L2/KEAP1 mutations in advanced NSCLC with the TORC1/2 inhibitor TAK-228
    Journal Article

    Paik, P. K.; Fan, P. D.; Qeriqi, B.; Namakydoust, A.; Daly, B.; Ahn, L.; Kim, R.; Plodkowski, A.; Ni, A.; Chang, J.; more...
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save
  • In reply to “Selpercatinib controls central nervous system disease in patients with RET fusion-positive NSCLC”
    Correspondence

    Murciano-Goroff, Y. R.; Lin, S. T.; Wilhelm, C.; Iasonos, A.; Drilon, A.
    Journal of Thoracic Oncology (2023)

    Fulltext@MSK | Save